New phone therapy aims to ease anxiety in older cancer patients

NCT ID NCT03168971

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a telephone-based therapy called Managing Anxiety from Cancer (MAC) for older adults (65+) with cancer and their caregivers. The therapy includes seven sessions covering relaxation, communication, and problem-solving skills. The goal was to see if it reduces anxiety better than usual care. Only 26 people took part, so results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Managing Anxiety from Cancer (MAC) therapy (telephone-administered psychological intervention)

What this could lead to

If it works, this could provide a practical, home-based therapy to reduce anxiety and improve quality of life for older cancer patients and their caregivers.

What could go wrong

This is a very small pilot study with only 26 participants, so results may not apply to everyone. The therapy is still experimental and may not be more effective than usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder breast cancer Depression depressive disorder digestive system cancer female reproductive organ cancer lymphoma malignant urinary system neoplasm neoplasm thoracic cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States